Skip to content
Recall Observatory FDA recall evidence

Drug product

NOREPINEPHRINE, 8 mg per 250 mL, (32 mcg per mL) in 0.9% Sodium Chloride Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-676-01.

D-0321-2022

November 12, 2021

Class II

Product summary

Firm
SterRx, LLC
Event
Event 89059
Status
Terminated
Classification
Class II
Quantity
74,508 bags
Official record key
drug-enforcement:D-0321-2022

Official wording

Reason: Lack of Assurance of Sterility

Code information: S21162/BTT 13-Nov-21 S21163/BTU 13-Nov-21 S21167/BTY 19-Nov-21 S21174/BUF 20-Nov-21 S21175/BUG 21-Nov-21 S21217/BVS 12-Dec-21 S21218/BVT 12-Dec-21 S21219/BVU 16-Dec-21 S21241/BWL 24-Dec-21 S21281/BXY 20-Jan-22 S21282/BXZ 23-Jan-22 S21283/BYA 22-Jan-22 S21297/BYN 28-Jan-22 S21340/CAA 27-Feb-22 S21342/CAC 5-Mar-22 S21352/CAL 6-Mar-22 S21359/CAS 11-Mar-22 S21362/CAV 12-Mar-22 S21368/CBB 13-Mar-22 S21369/CBC 19-Mar-22 S21415/CCX 7-Apr-22 S21419/CDB 7-Apr-22 S21434/CDP 16-Apr-22

Distribution pattern: U.S.A. Nationwide

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility